Evidence map›Paper›PMID 34757320›Full record

ArticleJournal of medical Internet research2021

Cancer Communication and User Engagement on Chinese Social Media: Content Analysis and Topic Modeling Study.

Liang Chen, Pianpian Wang, Xin Ma, Xiaohui Wang

Abstract read
In one paragraph

Article in Journal of medical Internet research, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Liang ChenSchool of Journalism and Communication, Tsinghua University, Beijing, China.ORCID 0000-0003-0968-2936
Pianpian WangSchool of Media and Communication, Shenzhen University, Shenzhen, China.ORCID 0000-0001-7529-0880
Xin MaDepartment of Communication, University of Maryland, Maryland, MD, United States.ORCID 0000-0001-6250-7737
Xiaohui WangDepartment of Media and Communication, City University of Hong Kong, Hong Kong, China.ORCID 0000-0003-2126-1712

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundCancer ranks among the most serious public health challenges worldwide. In China-the world's most populous country-about one-quarter of the population consists of people with cancer. Social media has become an important platform that the Chinese public uses to express opinions.

objectiveWe investigated cancer-related discussions on the Chinese social media platform Weibo (Sina Corporation) to identify cancer topics that generate the highest levels of user engagement.

methodsWe conducted topic modeling and regression analyses to analyze and visualize cancer-related messages on Weibo and to examine the relationships between different cancer topics and user engagement (ie, the number of retweets, comments, and likes).

resultsOur results revealed that cancer communication on Weibo has generally focused on the following six topics: social support, cancer treatment, cancer prevention, women's cancers, smoking and skin cancer, and other topics. Discussions about social support and cancer treatment attracted the highest number of users and received the greatest numbers of retweets, comments, and likes.

conclusionsOur investigation of cancer-related communication on Weibo provides valuable insights into public concerns about cancer and can help guide the development of health campaigns in social media.

Indexed as

COVID-19NeoplasmsSocial MediaChinaCommunicationFemaleHumansSARS-CoV-2cancercancer-related informationsocial mediatopic modelinguser engagementWeibo

Identifiers

PMID34757320
PMCPMC8663448

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.